1-1 of 1
Nahoko Nishimoto, MD
Close
Sort by
Journal Articles

AML1/Runx1 Is a Cytoplasmic Attenuator of NF-Kb Signaling: Implication in Pathogenesis and Targeted Therapy of AML1-Related Leukemia.

Masahiro Nakagawa, Munetake Shimabe, Nahoko Nishimoto, MD, Naoko Watanabe-Okochi, Motoshi Ichikawa, Yasuhito Nannya, Yoichi Imai, Mineo Kurokawa
Journal: Blood
Blood (2009) 114 (22): 1962.
https://doi.org/10.1182/blood.V114.22.1962.1962
Published: 2009